Last Updated: June 24, 2026

LEVORPHANOL Drug Patent Profile

Name: LEVORPHANOL Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Levorphanol, and what generic alternatives are available?

Levorphanol is a drug marketed by Acertis Pharms, Hikma, Novitium Pharma, Specgx Llc, and Sun Pharm Inds Inc. and is included in five NDAs.

The generic ingredient in LEVORPHANOL is levorphanol tartrate. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the levorphanol tartrate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Levorphanol

A generic version of LEVORPHANOL was approved as levorphanol tartrate by HIKMA on March 31^st, 2000.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for LEVORPHANOL?
What are the global sales for LEVORPHANOL?
What is Average Wholesale Price for LEVORPHANOL?

Summary for LEVORPHANOL

US Patents:	0
Applicants:	5
NDAs:	5
Drug Prices:	Drug price information for LEVORPHANOL
DailyMed Link:	LEVORPHANOL at DailyMed

Drug patent expirations by year for LEVORPHANOL

US Patents and Regulatory Information for LEVORPHANOL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Acertis Pharms	LEVORPHANOL TARTRATE	levorphanol tartrate	TABLET;ORAL	211484-001	Dec 13, 2018	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Novitium Pharma	LEVORPHANOL TARTRATE	levorphanol tartrate	TABLET;ORAL	213479-002	Jan 12, 2021	BX	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hikma	LEVORPHANOL TARTRATE	levorphanol tartrate	TABLET;ORAL	074278-003	Jun 18, 2018		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.